Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Novo Nordisk A/S (NYSE: NVO) weakened during the last several trading days. NVO’s current Value Trend Rating is C and the prior Rating was B. Details supporting this lower rating are included in our next report.
Recent Price Action
On 1/5/24, Novo Nordisk A/S (NYSE: NVO) stock declined modestly by -1.5%, closing at $105.98. This decline was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 2.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, NVO is expected to continue to be a major Value Builder.
Novo Nordisk A/S has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Novo Nordisk A/S has a slightly negative Appreciation Score of 39 but a very high Power Rating of 88, with the High Neutral Value Trend Rating the result.
Be the first to comment